Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saizen for Short Stature in Young Girls with Turner Syndrome
NCT01066052Phase 4Completed
- Sponsor
- Merck KGaA
- Start
- Feb 1992
- Primary completion
- Mar 1999
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of somatropin in Turner syndrome (TS), sponsored by Merck KGaA. Started Feb 1992; status: completed.
02
Drugs
somatropin
03
Conditions
Turner syndrome (TS)
Beyond the preview
Go deeper on NCT01066052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01066052.